This is not marketing hype
Watch the first part now: Read the full review in the The Lancet Group: Matthias Blher Matthias Tschpe Katherine Tuttle Michael Weintraub, MD To view or add a comment, sign in Weight change is a surrogate outcome for improved cardiometabolic outcomes
Zeevi K, Volanek , Katsiki N, et al
See Omzo GLP-1 Program Details, Pricing, and Current Availability Prescription medication is available only if a licensed clinician determines it is clinically appropriate
Poor sleep or disturbed sleep disrupts your nervous systems reset, increasing irritability, reducing focus, and messing with mood
Your GP can also provide evidence-based guidance on lifestyle modifications that naturally support incretin function, such as: Adopting a diet rich in whole foods, vegetables, and dietary fibre Achieving and maintaining a healthy body weight Engaging in regular physical activity Optimising sleep and stress management These interventions have robust evidence for improving metabolic health and may naturally enhance GLP-1 and GIP secretion without the need for supplements
